centers for disease control and prevention
play

Centers for Disease Control and Prevention. 1 . Stop Norovirus: - PowerPoint PPT Presentation

The Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California Immunization Coalition, funded through a cooperative agreement with the Centers for Disease Control


  1. The Virtual Immunization Communication (VIC) Network is a project of the National Public Health Information Coalition (NPHIC) and the California Immunization Coalition, funded through a cooperative agreement with the Centers for Disease Control and Prevention. 1

  2. . Stop Norovirus: Protect Yourself and Others Webinar Objectives • Provide overview of norovirus and the disease burden. • Learn how to prevent and control Norovirus. • Understand issues and challenges related to norovirus vaccine development. • Highlight surveillance systems that track norovirus outbreaks. • Highlight CDC norovirus communication materials available for various audiences 2

  3. A nationwide ‘virtual’ immunization community of health educators, public health communicators and others who promote immunizations. 3

  4. Access the Q&A Panel From Split Screen Welcome to the Webcast! We Will Be Starting Momentarily.

  5. Questions for Presenters? 5

  6. Frequently Asked Questions 1. Will I be able to get a copy of the slides after the webinar?  Yes – a copy will be posted on the VICNetwork.org site 2. Will I receive a copy of the webinar recording?  Yes - a copy will be posted on the VICNetwork.org site

  7. TITLE of PRESENATION Jessica Allen, MSW, MPH Health Communications Specialist, Northrup Grumman 7

  8. Daniel C. Payne , PhD, MSPH Principal Investigator and Project Officer, Centers For Disease Control and Prevention 8

  9. Stop Norovirus: Protect Yourself and Others Daniel Payne PhD, MSPH Jessica Allen MPH, MSW Virtual Immunization Communication Network Wednesday March 23, 2016 Department of Health and Human Services Centers for Disease Control and Prevention

  10. Poll Question  What acute gastroenteritis pathogen causes the most cases of diarrheal disease each year? a. Rotavirus b. Norovirus c. E.coli d. Salmonella e. Shigella f. Clostridium difficile

  11. NOROVIRUSES: PERFECT HUMAN PATHOGEN? Highly contagious Rapidly and prolifically shed Diverse and constantly evolving Evoke limited immunity Moderately virulent

  12. Highly Contagious  How Norovirus Spreads • Water & Foodborne o eating food or drinking liquids that are contaminated with norovirus • Environmental o touching surfaces or objects contaminated with norovirus then putting your fingers in your mouth • Person-to-Person o having contact with someone who is infected with norovirus http://www.cdc.gov/norovirus/multimedia.html

  13. Moderately virulent  Common norovirus symptoms include: • diarrhea • vomiting • nausea • stomach pain http://www.cdc.gov/norovirus/index.html Symptoms usually develop 12 to 48 hours after exposure  Most people get better within 1 to 3 days  Young children and the elderly are more likely to have  severe illness There’s no specific treatment for norovirus other than  making sure people stay hydrated

  14. Rapidly and prolifically shed • Shed mainly in stool, but also in vomit • Shedding occurs for at least 2-3 weeks • Peaks 4 days after exposure – Can persist after resolution of symptoms • Infectious dose: 18-2,800 viral particles • Infectivity of prolonged viral http://www.cdc.gov/vitalsigns/norovirus/infographic.html#graphic shedding and role in transmission is unknown

  15. Diverse and constantly evolving Classification of Noroviruses GII.4 • cause >75% of disease • Causes more severe disease

  16. Produces Time-Limited Immunity  Human studies have found immunity to norovirus may last 6 – 24 months  Mathematical modeling based on observed disease suggests immunity may last for as long as 4 – 8 years

  17. Annual Burden of Norovirus Disease in the U.S. 570 – 800 Deaths, mostly in young children and the elderly 56,000 – 71,000 Hospitalizations 400,000 Emergency Department Visits 1.7 – 1.9 million Outpatient Visits 19 – 21 million Total Illnesses

  18. Poll Question  What types of norovirus communication materials would be most helpful for the work you do? a. Prevention and control fact sheet for patients/public b. Prevention and control posters for placement in offices and public heath buildings c. Multimedia prevention materials such as infographics and videos d. Other

  19. REPORTING AND SURVEILLANCE

  20. U.S. Norovirus Outbreak Surveillance • NORS – Epidemiologic surveillance for all enteric disease outbreaks – Data on setting, transmission mode, exposures, demographics, outcomes

  21. U.S. Norovirus Outbreak Surveillance • CaliciNet – Laboratory surveillance using molecular genotyping of outbreak- associated specimens – Data on genotypes to identify new strains and potentially link outbreaks http://www.cdc.gov/norovirus/reporting/calicinet/index.html

  22. NoroSTAT: Norovirus Sentinel Testing and Tracking • Near-real time reporting of norovirus outbreaks by network of sentinel states – Implemented August 2012 in 5 states – Expanded to 7 in 2015 and 9 planned for 2016 – Improved timeliness, completeness, and linking of outbreak reports in NORS and CaliciNet http://www.cdc.gov/norovirus/reporting/norostat/flowchart.html

  23. Active, Prospective Pediatric Surveillance • NVSN: New Vaccine Surveillance Network – Enrolls children visiting a participating hospital or emergency department with diarrhea and /or vomiting. – Obtains epidemiologic data, clinical data, specimens and vaccination histories – Assesses disease burden http://www.cdc.gov/surveillance/nvsn/index.html among US children

  24. NOROVIRUS TRENDS AND OUTBREAKS

  25. http://www.cdc.gov/norovirus/trends-outbreaks.html

  26. Transmission Mode of Norovirus Outbreaks, NORS, 2009-2012 (N=4,318) Foodborne Environmental 23% 0.3% Waterborne Unknown 0.3% 7% Person-to- person 69%

  27. Setting of Norovirus Outbreaks, NORS, 2009-2012 (N=3,243) Restaurants 17% Schools 5% Caterer/Banquet Facility 5% Hospitals 3% Private Long-Term Care Residence Facilities 2% 59% Daycares 2% Other/Multiple 7%

  28. Norovirus Outbreak Settings • Norovirus is the leading cause of illness and outbreaks from contaminated food in the United States http://www.cdc.gov/vitalsigns/norovirus/infographic.html#infographic

  29. Pediatric burden of norovirus • NVSN surveillance found that norovirus is now the most common and costly cause of severe gastroenteritis in U.S. kids seeking medical care • Norovirus is responsible for ~1 million pediatric medical care visits in the U.S. each year

  30. PREVENTION AND CONTROL

  31. How to Prevent Norovirus Infection Wash your hands carefully with 1. soap and water Wash fruits and vegetables and 2. cook seafood thoroughly When you are sick, do not prepare 3. food or care for others who are sick Clean and disinfect contaminated 4. surfaces Wash laundry thoroughly 5. http://www.cdc.gov/norovirus/multimedia.html

  32. Preventing Norovirus in Long Term Care Facilities http://www.cdc.gov/norovirus/images/stop-norovirus-lg.jpg

  33. Preventing Norovirus in Food Settings http://www.cdc.gov/vitalsigns/norovirus/infographic.html#infographic

  34. Preventing and Controlling Norovirus http://www.disinfect-for-health.org/resources

  35. NOROVIRUS VACCINE

  36. GI.1 intranasal GI.1/GII.4 intramuscular

  37. Norovirus Vaccine Development • Two randomized trials involving healthy adults ages 18-50. 1. Intranasally delivered Norwalk virus (genotype GI.1) VLP vaccine followed by homologous challenge – Vaccine protected against illness (~50%) and decreased infection frequency (~25%) – First demonstration that a norovirus vaccine can prevent disease 2. Intramuscular bivalent (GI.1 and consensus GII.4) VLP vaccine followed by GII.4 challenge – Did not significantly reduce illness or infection, but did reduce disease severity and decreased viral shedding – Hampered by low disease rate from challenge and high baseline infection rate in control group

  38. Challenges for a norovirus vaccine – Role of prior infection history? – Duration of protection? – Protection against multiple genotypes? – Need to be updated to keep up with viral evolution? – Need for different vaccine formulation for certain groups? – Variation in human genetic susceptibility? http://www.cdc.gov/norovirus/downloads/global-burden-report.pdf

  39. Poll Question  If a norovirus vaccine was licensed and shown to be effective in preventing norovirus infection, would you get it yourself or have your child get it? a. Get it myself b. Have my child get it c. Get it myself and have my child get it d. No

  40. ADDITIONAL NOROVIRUS COMMUNICATION MATERIALS

  41. A good place to start for materials: http://www.cdc.gov/norovirus/about/index.html

  42. Communications: For Health Care Providers http://www.cdc.gov/hai/pdfs/norovirus/229110-ANoroCaseFactSheet508.pdf http://www.medscape.com /viewarticle/778880

  43. Communications: For Food Workers http://www.cdc.gov/norovirus/downloads/foodhandlers.pdf http://www.cdc.gov/norovirus/multimedia.html

  44. Communication: For Everyone http://www.cdc.gov/norovirus/multimedia.html http://www.cdc.gov/norovirus/downloads/keyfacts.pdf

  45. Special Thanks Aron Hall Ben Lopman Mary Wikswo Jeanette St. Pierre

Recommend


More recommend